Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)

Background. Adenovirus serotype 26 (Ad26) has been developed as a novel candidate vaccine vector for human immunodeficiency virus type 1 (HIV-1) and other pathogens. The primary safety and immunogenicity data from the Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) 001 tria...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Barouch, Dan H., Liu, Jinyan, Peter, Lauren, Abbink, Peter, Iampietro, M. Justin, Cheung, Ann, Alter, Galit, Chung, Amy, Dugast, Anne-Sophie, Frahm, Nicole, McElrath, M. Juliana, Wenschuh, Holger, Reimer, Ulf, Seaman, Michael S., Pau, Maria G., Weijtens, Mo, Goudsmit, Jaap, Walsh, Stephen R., Dolin, Raphael, Baden, Lindsey R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Major Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532832/
https://ncbi.nlm.nih.gov/pubmed/23125443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis671
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak